My research focuses on the occurence of nocebo-effects in statin-intolerant. We try to identify patients who are statin-intolerant and that suffer from these effects. We hope that by identifying patients affected by the nocebo effect and allowing them to experientially understand its impact through an N=1 study design, they will experience fewer side effects from their statin treatment. This may help prevent the need to switch to expensive PCSK9 inhibitors.
Cost benefit analysis clinical medication reviews. Follow up of interventions from clinical pharmacists. Medication information needs of hospitalized patients.
Het doel is het effect van farmacokinetische boosting op de farmacokinetiek, effectiviteit en toxiciteit van behandeling met olaparib te onderzoeken.
European funded project to reduce the inappropriate use of antibiotics in common infectious diseases by implementing EU guidelines for the prudent use of antimicrobials in human health. Implementing the Audit Project Odense (APO) methodology in community pharmacies in 5 European countries (France, Spain, Lithuania, Poland and Greece).